Navigation Links
UGA, Emory to study how exercise may prevent drug abuse relapse
Date:4/29/2010

Athens, Ga. A team of researchers at the University of Georgia and Emory University will receive $1.9 million over the next five years from the National Institutes of Health to study the neurobiological mechanisms for how regular aerobic exercise may prevent drug abuse relapse.

"Drug abuse is closely linked to stress, and one of the most challenging aspects of treating addiction is preventing the relapse caused by stress," said Philip Holmes, professor of psychology in the Franklin College of Arts and Sciences and a co-investigator on the project. "Despite many years of research, no universal treatment to prevent relapse exists."

Previous research in Holmes' lab has demonstrated that exercise exerts anti-stress effects. A chemical called galanin, which increases in the brain during exercise, appears to reduce cravings associated with stress.

"Stress turns on norepinephrine," said Holmes, "which turns on dopamine, which induces craving. Galanin decreases norepinephrine, so someone with high levels of galanin should experience reduced cravings."

For the project, Holmes will measure exercise-induced increases of the galanin gene activity in the rat brain. "These experiments will establish the relationship between exercise and galanin gene expression, and support the hypothesis that exercise-induced regulation of galanin protects against over-activation of the norepinephrine system, thereby preventing drug self-administration following stress."

"This research will provide new insight into how regular exercise may attenuate drug abuse in humans," said David Weinshenker, associate professor of human genetics in Emory University's School of Medicine, and a co-principal investigator on the project. "More importantly, it may reveal a neural mechanism through which exercise may prevent the relapse into drug-seeking behavior."

Dr. Gaylen Edwards, professor and head of the department of physiology and pharmacolog
'/>"/>

Contact: Laurie Anderson
laurie@uga.edu
706-583-0599
University of Georgia
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Memory Loss Supplement Manufacturer Partners With Nationally-Syndicated Radio Host John Tesh
2. To Boost Your Memory, Take a Break
3. Immune memory formation seen in early stages of viral infection
4. Brain scientists extend map of fear memory formation
5. Discovery of epigenetic memory during breast cancer
6. Study shows link between working memory and reactive parenting
7. Neuralstem Receives Approval To Commence First ALS Stem Cell Trial at Emory ALS Center
8. InfoZoom Launches V6.4 of its Industry Leading In-Memory Data Analysis Software
9. Healthy older adults with subjective memory loss may be at increased risk for MCI and dementia
10. €1.6 million ($2.32 million) grant awarded to Prof. Kobi Rosenblum for brain and memory research
11. The Run for the Memory Marathon Team Getting in Shape and Fighting Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... a study in 2012 suggested a cancer drug ... with Alzheimer,s disease, three groups of researchers now ... findings. The teams said their research could ... drug involved in the study, bexarotene (Targretin), has ... pancreatitis, headaches, fatigue, weight gain, depression, nausea, vomiting, ...
(Date:5/23/2013)... Emory Vaccine Center have shown that an immune regulatory ... in mice against viral infections. , The results are ... "Our findings highlight how IL-21 could be important in ... Ur Rasheed Mohammed, PhD, the first author of the ... of the Emory Vaccine Center and a Georgia Research ...
(Date:5/23/2013)... Chicago, IL (PRWEB) May 23, 2013 ... of comprehensive solutions and educational resources for the ... today that it is opening its first global ... in the Philippines in August. This new world-class ... the best of Western evidence-based practices to treat ...
(Date:5/23/2013)... 23, 2013 Six innovative research projects ... by Lyme Research Alliance, the nation's largest private nonprofit funder ... studies focus on the epidemiology of, and treatment and ... “LRA is proud to support the innovative research being ... men and women in the field today,” said Harriet ...
(Date:5/23/2013)... researchers examining outcomes for advanced heart-failure patients over ... with the increased availability and use of new ... death, caused by the rapid onset of severe ... However, the team found that even today, with ... more than three years after being diagnosed with ...
Breaking Medicine News(10 mins):Health News:Scientists Can't Replicate Surprising Finding on Alzheimer's Treatment 2Health News:Vaccine blackjack: IL-21 critical to fight against viral infections 2Health News:Special Learning, Inc. to Expand its Services for Individuals with Special Needs with Opening of New Special Education School in the Philippines 2Health News:Special Learning, Inc. to Expand its Services for Individuals with Special Needs with Opening of New Special Education School in the Philippines 3Health News:Six Investigators Awarded Lyme Research Alliance Grants 2Health News:Six Investigators Awarded Lyme Research Alliance Grants 3Health News:Six Investigators Awarded Lyme Research Alliance Grants 4Health News:Death rates decline for advanced heart failure patients, but outcomes are still not ideal 2Health News:Death rates decline for advanced heart failure patients, but outcomes are still not ideal 3
... For immediate release -- Sept. 22, 2011 (Toronto) -- A ... recommends a public health approach to cannabis - including evidence-based ... that result from the use of cannabis. Led ... (Simon Fraser University, Vancouver) Dr. Benedikt Fischer, the study is ...
... class of medicines commonly given for pain -- were associated ... 3,061 adults, aged 65 to 94, e-published in advance of ... . The study from researchers at Group Health Research Institute ... which are drugs generally given for insomnia and anxiety, did ...
... 22 (HealthDay News) -- There were 134 waterborne disease ... in the United States in 2007-08, and 36 outbreaks ... released Thursday. The 134 recreational water illness outbreaks ... in 38 states and Puerto Rico, caused at least ...
... , THURSDAY, Sept. 22 (HealthDay News) -- Almost 7 percent of ... hospitalized within 30 days of the procedure, a new study indicates. ... who do not get prostate biopsies can expect to be hospitalized, ... Journal of Urology . "The overall hospitalization rate is about ...
... , THURSDAY, Sept. 22 (HealthDay News) -- Over-the-counter asthma ... layer, will not be made or sold after Dec. ... The sole product affected is Primatene Mist, marketed ... inhaler approved by the FDA to be sold without ...
... - The University of Kentucky,s Dr. Susanne Arnold and colleagues ... study potential environmental reasons for the high lung cancer rates ... three years and the study began on Sept. 15. ... but counties in the southeastern portion of the state ...
Cached Medicine News:Health News:New study proposes public health guidelines to reduce the harms from cannabis use 2Health News:New study proposes public health guidelines to reduce the harms from cannabis use 3Health News:Opioids linked to higher risk of pneumonia in older adults 2Health News:Infections Linked to Swimming, Drinking Water: CDC 2Health News:In Older Men, Prostate Biopsies Can Raise Risk of Hospitalization 2Health News:In Older Men, Prostate Biopsies Can Raise Risk of Hospitalization 3Health News:Asthma Inhaler Primatene Mist Going Off the Market 2Health News:Lung cancer research team awarded $1.43 million to study cancer in Eastern Kentucky 2Health News:Lung cancer research team awarded $1.43 million to study cancer in Eastern Kentucky 3
(Date:5/23/2013)... 23, 2013  Inhibikase Therapeutics, Inc., an emerging ... it will present new results on its antiviral ... sponsored by the PML Consortium (composed of Pfizer, ... (JCV) is the causative agent of Progressive Multifocal ... in an extended release formulation, can clear JC ...
(Date:5/23/2013)... 23, 2013 InspireMD, Inc. ... leader in embolic protection stents, today announced new ... ST Elevation Reperfusion) trial demonstrating that the MGuard ... drug eluting stents in all-cause mortality in ST ... the trial were presented at the InspireMD STEMI ...
(Date:5/23/2013)... and PARIS , May 23, ... a leading developer and manufacturer of precision guided therapy ... coronary and peripheral vascular disease, today announced preliminary results ... I ndependent S tenosis E valuation) ... trial session at EuroPCR 2013. These prospective results confirm ...
Breaking Medicine Technology:Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 2Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 3Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 4Volcano Announces Preliminary Results from the ADVISE II Study and Inclusion in the SYNTAX2 Trial During Hot Line Late Breaking Clinical Trial Sessions at EuroPCR 2013 5
... BAY, Wis., Sept. 7, 2011 ... solutions to hospitals, IDNs, healthcare systems and clinics, ... of the Centers for Medicare & Medicaid Services ... Medical Documentation (esMD).  (Logo: http://photos.prnewswire.com/prnh/20110907/PH63482LOGO) ...
... 7, 2011 As NFL coaches and players face a ... one team,s preparation will be gaining a competitive edge as ... season. Today, Polar USA and the Atlanta Falcons announced that ... "Official Heart Rate Training System" of the Atlanta Falcons. ...
Cached Medicine Technology:IOD to Enter Testing Phase in CMS esMD Pilot Program 2Polar Team2 Pro Set Solution Is Official Heart Rate Training System for the Atlanta Falcons 2Polar Team2 Pro Set Solution Is Official Heart Rate Training System for the Atlanta Falcons 3
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
... The Research pro Electronic Pipette is ... the laboratory. Its easy-to-follow display, ergonomically-placed operating ... pipetting, dispensing, reverse pipetting and diluting make ... the simple functions of a manual pipette ...
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
... best value in high performance electronic pipetting!, ... design reduce hand fatigue and strain , ... ejector , Color coding for easy volume ... greater performance use Hamilton AdvanTip Low Retention ...
Medicine Products: